SciELO - Scientific Electronic Library Online

vol.61 issue3The usefulness of the filtration-adhesion method in urine cytologyDa Vinci® robot assisted radical prostatectomy: one year experience at the Hospital Clínico San Carlos author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614


GONZALO RODRIGUEZ, Victoria et al. The use of NMP22 Bladder-Chek for the diagnosis and folow-up of bladder cancer. Arch. Esp. Urol. [online]. 2008, vol.61, n.3, pp.377-384. ISSN 0004-0614.

Objectives: The goal of this work is to evaluate the usefulness of NMP22 BladderChek in the diagnosis and follow-up of bladder cancer, comparing it with cystoscopy and urine cytology. Methods: Group 1: 109 asymptomatic patients on follow up for bladder cancer underwent cystoscopy, cytology and NMP22 BladderChek. Group 2: 15 patients with history of hematuria underwent cystoscopy and NMP22 BladderChek. Results: Group 1: 9 patients had tumor relapse. Sensitivity was 25% for NMP22 test, 50% for citology and 100% for cystoscopy. Specificity was 91.1%, 94.1% and 95% respectively. Group 2: 12 patients had bladder cancer. The sensitivity was of 83.3% for NMP22 BladderChek and 100% for cystoscopy. The specificity was of 100% for NMP22 BladderChek and 66.7% for cystoscopy. Conclusions: The low sensitivity of NMP22 Bladder-Chek invalidates it as alternative method to cystoscopy in the follow-up of bladder cancer. But it can be recommended for screening in patients without history of bladder cancer but with an increased risk (smokers, patients with dysuria and hematuria).

Keywords : Bladder Cancer; NMP22 BladderChek; Cystoscopy; Citology.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License